Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROFIT study of preoperative BOTOX for prevention of postoperative pancreatic fistula after distal pancreatectomy
NL-OMON48251Phase 2Recruiting
- Sponsor
- Erasmus MC
- Start
- Sep 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of botulinum toxin type A in pancreatic fistula (POPF), sponsored by Erasmus MC. Started Sep 2019; status: recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
pancreatic fistula (POPF)
Beyond the preview
Go deeper on NL-OMON48251.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON48251.